[1]
“PREVALENCE, ETIOLOGY, AND PRESCRIPTION PATTERNS IN PATIENTS WITH MEMBRANOUS TONSILLITIS AND UPPER RESPIRATORY TRACT INFECTION”, Int. Res. J. Pharm., vol. 10, no. 8, pp. 123–128, Aug. 2019, Accessed: Aug. 16, 2026. [Online]. Available: https://irjponline.org/index.php/irjp/article/view/3060